Saturday July 04 2009 | Biotechnology feed | All feeds
Cytotoxics remain standard bearers The Board of International Biotechnology Trust Plc (“IBT”) today announces its unaudited Annual Results for the twelve months ended 31 August 2005 MOUSE GENES OFF THE SHELF Geneservice and RZPD to distribute DNABookTM York Pharma founds Japanese operating company and appoints President Epitan Completes Recruitment and Dosing for Photoprotection Trial in Sydney IMMUTEP Appoints Michel Greco To Board Of Directors SR Pharma: Interim results for the six months ended 30 June 2005 Pioneer of drug discovery data management software recognized for his contribution to the industry IDBS launches ActivityBase XE – revolutionary solution for high throughput screening data management Apollo grows with acquisition $60 billion of pharmaceutical company revenues under threat from generic drugs LifePharms, Inc. Receives Approval for Phase II SBIR Grant for Cancer Research from NIH Lipoxen announces collaboration agreements with Baxter Healthcare & two other biopharmaceutical companies Epitan begins PMLE trial in Melbourne Singvax And Octoplus Announce Collaboration To Develop Single-Shot Japanese Encephalitis Vaccine CellCentric and Cancer Research Technology initiate co-development partnership GM food avoidance policies to become more expensive, according to new report RNTECH & DNAVision Announce A Co-Marketing Agreement To Offer A Complete Solution For Biomarker And Target Discovery In Oncology York Pharma appoints new Chairman Launch of East Midlands bioscience knowledge exchange initiative Millipore and Oxford Immunotec Co-develop Plates for Diagnosing and Monitoring Infections G-BOX, a New Concept in Image Analysers Offers the World’s First Affordable Custom Designed System Cytheris launches a new Phase I clinical trial in the US for its recombinant Interleukin-7 DE NOVO LAUNCHES REFLEX, A MAJOR UPGRADE TO ITS IN SILICO DRUG DESIGN PLATFORM Novagali Pharma completes a Phase I clinical trial in oncology with its oral formulation of Paclitaxel Eyes turning to Neuropathic pain market New Order for Biacore®A100 Received from Major Pharmaceutical Company ViRexx completes $4 million private placement Phase I ProCord Study Results Published in the Journal of Neurosurgery: Spine September 2005 Issue Agilent Technologies launches ChIP-on-chip microarray platform, enabling researchers to analyze gene regulation Drug Safety in the Post-Vioxx Era Antibacterial hope lies in clever drugs for superbugs M&A is not the only way Merck & Co - Amrad: an uncertain pathway to success Doubling up in battle to beat cholesterol Epitan receives ethics approval for Phase II PMLE trial at St Vincent's Hospital in Melbourne EuropaBio is delighted to partner BIOTECHNICA 2005 and encourages the biotech industry to visit this international trade fair in Hannover this year New vaccine offers better protection against pulmonary tuberculosis Bayer Selects InforSense for Next Generation Integrative Analytics Infrastructure - InforSense KDE to Provide Workflow-based Cheminformatics Platform P2i plan to extend pipette nano-coating success to other consumables and devices - Saving the very last drop Protagen AG - Powerful protein biochips for antibody development Liponex Develops Improved Formulation of CRD5 Oxford Biomedica Announces Appointment Of Chief Medical Officer Solexa And Collaborating Scientists Illuminate The Small RNA Component Of The Transcriptome BioPlanta GmbH and AnalytiCon Discovery GmbH announce their cooperation in the plant-based search for active ingredients DNAVision Is The First European Pharmacogenomic Service Laboratory To Succeed Iso/Iec 17025 Audit Northbank Communications strengthens team with two new staff additions CellCentric receives new funding from NESTA to further its work in epigenetics and cancer Innate Pharma obtains ISO9001:2000 certification for its research and development activity in the field of immunotherapy Evolva Acquires Pharmaceutical Business of Poalis York Pharma founds UK commercial operations unit and appoints Sales & Marketing Director BioNewsCast Press Release Service 2005 Archive BioNewsCast Press Release Service 2004 Archive BioNewsCast Press Release Service 2003 Archive BioNewsCast Press Release Service 2002 Archive BioNewsCast Press Release Service - Site Map
Cytotoxics remain standard bearers
The Board of International Biotechnology Trust Plc (“IBT”) today announces its unaudited Annual Results for the twelve months ended 31 August 2005
MOUSE GENES OFF THE SHELF Geneservice and RZPD to distribute DNABookTM
York Pharma founds Japanese operating company and appoints President
Epitan Completes Recruitment and Dosing for Photoprotection Trial in Sydney
IMMUTEP Appoints Michel Greco To Board Of Directors
SR Pharma: Interim results for the six months ended 30 June 2005
Pioneer of drug discovery data management software recognized for his contribution to the industry
IDBS launches ActivityBase XE – revolutionary solution for high throughput screening data management
Apollo grows with acquisition
$60 billion of pharmaceutical company revenues under threat from generic drugs
LifePharms, Inc. Receives Approval for Phase II SBIR Grant for Cancer Research from NIH
Lipoxen announces collaboration agreements with Baxter Healthcare & two other biopharmaceutical companies
Epitan begins PMLE trial in Melbourne
Singvax And Octoplus Announce Collaboration To Develop Single-Shot Japanese Encephalitis Vaccine
CellCentric and Cancer Research Technology initiate co-development partnership
GM food avoidance policies to become more expensive, according to new report
RNTECH & DNAVision Announce A Co-Marketing Agreement To Offer A Complete Solution For Biomarker And Target Discovery In Oncology
York Pharma appoints new Chairman
Launch of East Midlands bioscience knowledge exchange initiative
Millipore and Oxford Immunotec Co-develop Plates for Diagnosing and Monitoring Infections
G-BOX, a New Concept in Image Analysers Offers the World’s First Affordable Custom Designed System
Cytheris launches a new Phase I clinical trial in the US for its recombinant Interleukin-7
DE NOVO LAUNCHES REFLEX, A MAJOR UPGRADE TO ITS IN SILICO DRUG DESIGN PLATFORM
Novagali Pharma completes a Phase I clinical trial in oncology with its oral formulation of Paclitaxel
Eyes turning to Neuropathic pain market
New Order for Biacore®A100 Received from Major Pharmaceutical Company
ViRexx completes $4 million private placement
Phase I ProCord Study Results Published in the Journal of Neurosurgery: Spine September 2005 Issue
Agilent Technologies launches ChIP-on-chip microarray platform, enabling researchers to analyze gene regulation
Drug Safety in the Post-Vioxx Era
Antibacterial hope lies in clever drugs for superbugs
M&A is not the only way
Merck & Co - Amrad: an uncertain pathway to success
Doubling up in battle to beat cholesterol
Epitan receives ethics approval for Phase II PMLE trial at St Vincent's Hospital in Melbourne
EuropaBio is delighted to partner BIOTECHNICA 2005 and encourages the biotech industry to visit this international trade fair in Hannover this year
New vaccine offers better protection against pulmonary tuberculosis
Bayer Selects InforSense for Next Generation Integrative Analytics Infrastructure - InforSense KDE to Provide Workflow-based Cheminformatics Platform
P2i plan to extend pipette nano-coating success to other consumables and devices - Saving the very last drop
Protagen AG - Powerful protein biochips for antibody development
Liponex Develops Improved Formulation of CRD5
Oxford Biomedica Announces Appointment Of Chief Medical Officer
Solexa And Collaborating Scientists Illuminate The Small RNA Component Of The Transcriptome
BioPlanta GmbH and AnalytiCon Discovery GmbH announce their cooperation in the plant-based search for active ingredients
DNAVision Is The First European Pharmacogenomic Service Laboratory To Succeed Iso/Iec 17025 Audit
Northbank Communications strengthens team with two new staff additions
CellCentric receives new funding from NESTA to further its work in epigenetics and cancer
Innate Pharma obtains ISO9001:2000 certification for its research and development activity in the field of immunotherapy
Evolva Acquires Pharmaceutical Business of Poalis
York Pharma founds UK commercial operations unit and appoints Sales & Marketing Director
BioNewsCast Press Release Service 2005 Archive
BioNewsCast Press Release Service 2004 Archive
BioNewsCast Press Release Service 2003 Archive
BioNewsCast Press Release Service 2002 Archive
BioNewsCast Press Release Service - Site Map
Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.
All rights reserved. All other trademarks recognized. Copyright © 1997-2009 - BioPortfolio Limited.
